PerkinElmer and IDBS Announce Software Collaboration to Improve High Content Screening Outcomes for Drug Discovery Research
IDBS announced a collaboration with PerkinElmer, Inc. at the 6th Annual High Content Analysis Conference in San Francisco. The collaboration will be focused on improving data analysis and interpretation of High Content Screening (HCS), an enabling technology in the search for key cellular markers associated with human health and disease.
“The future of High Content Screening lies in an increased synergy between technologies that integrate vast image content with large compound sets, to generate actionable research data,” said Richard M. Eglen, Ph.D., president, Bio-discovery, PerkinElmer. “We feel this collaboration with IDBS is a timely and highly promising advance in giving researchers access to greater insights into the cell-based mechanisms of disease, as well as development of novel therapies based on greater understanding of the origins of diseases.”
Most read news
Other news from the department business & finance
These products might interest you
![Limsophy](https://img.chemie.de/Portal/Products/171141_oET-PI88c.png?tr=n-xl10)
Limsophy by AAC Infotray
Optimise your laboratory processes with Limsophy LIMS
Seamless integration and process optimisation in laboratory data management
![ERP-Software GUS-OS Suite](https://img.chemie.de/Portal/Products/657ad7f8305d2_qcEexclCZ.jpg?tr=n-xl10)
ERP-Software GUS-OS Suite by GUS
Holistic ERP solution for companies in the process industry
Integrate all departments for seamless collaboration
![Newsletter](https://img.chemie.de/assets/bionity/images/newsletter.png)
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.